Mieke E.R. Henfling

1.4k total citations
21 papers, 1.1k citations indexed

About

Mieke E.R. Henfling is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Mieke E.R. Henfling has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Mieke E.R. Henfling's work include Cell death mechanisms and regulation (5 papers), Ubiquitin and proteasome pathways (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Mieke E.R. Henfling is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Ubiquitin and proteasome pathways (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Mieke E.R. Henfling collaborates with scholars based in Netherlands, Germany and United States. Mieke E.R. Henfling's co-authors include Frans C. S. Ramaekers, Bert Schutte, Manon van Engeland, Christl Vermeij‐Keers, Μ. Borgers, Maurice J.B. van den Hoff, Chris Reutelingsperger, Stefan M. van den Eijnde, Waander L. van Heerde and Ernst‐Jan M. Speel and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Mieke E.R. Henfling

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mieke E.R. Henfling Netherlands 15 551 336 325 198 175 21 1.1k
Ge Zhou United States 17 1.1k 2.1× 380 1.1× 143 0.4× 109 0.6× 137 0.8× 32 1.8k
Christian Melle Germany 25 1.0k 1.8× 279 0.8× 71 0.2× 116 0.6× 163 0.9× 61 1.4k
Victor Stastny United States 15 917 1.7× 443 1.3× 177 0.5× 169 0.9× 119 0.7× 24 1.4k
Jay Shankar Canada 14 672 1.2× 177 0.5× 170 0.5× 230 1.2× 268 1.5× 17 1.0k
Ayman Oweida United States 19 336 0.6× 694 2.1× 73 0.2× 42 0.2× 423 2.4× 46 1.3k
Alasdair C. Stamps United Kingdom 12 694 1.3× 291 0.9× 83 0.3× 318 1.6× 71 0.4× 16 1.0k
Mark T. Boyd United Kingdom 21 710 1.3× 562 1.7× 81 0.2× 94 0.5× 95 0.5× 36 1.2k
Maria Zajac‐Kaye United States 28 1.2k 2.1× 833 2.5× 209 0.6× 116 0.6× 158 0.9× 65 1.9k
Shu-ichi Matsuzawa United States 11 1.1k 2.1× 392 1.2× 216 0.7× 174 0.9× 271 1.5× 18 1.5k
Jerry Y. Hsu United States 17 1.8k 3.2× 723 2.2× 208 0.6× 777 3.9× 142 0.8× 43 2.3k

Countries citing papers authored by Mieke E.R. Henfling

Since Specialization
Citations

This map shows the geographic impact of Mieke E.R. Henfling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke E.R. Henfling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke E.R. Henfling more than expected).

Fields of papers citing papers by Mieke E.R. Henfling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke E.R. Henfling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke E.R. Henfling. The network helps show where Mieke E.R. Henfling may publish in the future.

Co-authorship network of co-authors of Mieke E.R. Henfling

This figure shows the co-authorship network connecting the top 25 collaborators of Mieke E.R. Henfling. A scholar is included among the top collaborators of Mieke E.R. Henfling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke E.R. Henfling. Mieke E.R. Henfling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ummelen, Monique, Mieke E.R. Henfling, Manon van Engeland, et al.. (2020). Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix. Cancer Medicine. 9(17). 6330–6343. 9 indexed citations
2.
Hopman, Anton H. N., Monique Ummelen, Mieke E.R. Henfling, et al.. (2019). SOX17 expression and its down‐regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma. Histopathology. 76(3). 383–393. 16 indexed citations
3.
Henfling, Mieke E.R., Aurel Perren, Anja Schmitt, et al.. (2018). The IGF pathway is activated in insulinomas but downregulated in metastatic disease. Endocrine Related Cancer. 25(12). 1005–1018. 7 indexed citations
4.
Huebbers, Christian U., Nadine C. Olthof, Jutta Kolligs, et al.. (2018). Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV‐negative tumors is an indicator of poor prognosis. International Journal of Cancer. 144(10). 2465–2477. 27 indexed citations
5.
Olthof, Nadine C., Ernst‐Jan M. Speel, Jutta Kolligs, et al.. (2014). Comprehensive Analysis of HPV16 Integration in OSCC Reveals No Significant Impact of Physical Status on Viral Oncogene and Virally Disrupted Human Gene Expression. PLoS ONE. 9(2). e88718–e88718. 83 indexed citations
6.
Olthof, Nadine C., Christian U. Huebbers, Jutta Kolligs, et al.. (2014). Viral load, gene expression and mapping of viral integration sites in HPV16‐associated HNSCC cell lines. International Journal of Cancer. 136(5). E207–18. 86 indexed citations
7.
Swarts, Dorian R.A., Mieke E.R. Henfling, Leander Van Neste, et al.. (2013). CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids. Clinical Cancer Research. 19(8). 2197–2207. 67 indexed citations
8.
Swarts, Dorian R.A., Leander Van Neste, Mieke E.R. Henfling, et al.. (2013). An exploration of pathways involved in lung carcinoid progression using gene expression profiling. Carcinogenesis. 34(12). 2726–2737. 48 indexed citations
9.
Marceau, Normand, Bert Schutte, Stéphane Gilbert, et al.. (2007). Dual roles of intermediate filaments in apoptosis. Experimental Cell Research. 313(10). 2265–2281. 62 indexed citations
10.
Schutte, Bert, Mieke E.R. Henfling, & Frans C. S. Ramaekers. (2006). DEDD association with cytokeratin filaments correlates with sensitivity to apoptosis. APOPTOSIS. 11(9). 1561–1572. 21 indexed citations
11.
Schutte, Bert, Mieke E.R. Henfling, Wendy Kölgen, et al.. (2004). Keratin 8/18 breakdown and reorganization during apoptosis. Experimental Cell Research. 297(1). 11–26. 171 indexed citations
12.
Henfling, Mieke E.R., F.C.S. Ramaekers, & B. Schütte. (2004). Proteasomes act in the pre-mitochondrial signal transduction route towards roscovitine-induced apoptosis. International Journal of Oncology. 25(5). 1437–46. 5 indexed citations
13.
Schütte, B., et al.. (2004). Inhibition of the cell cycle and induction of apoptosis by Noclosan and Loxat in cell lines irrespective of their origin.. PubMed. 24(6). 1357–67. 1 indexed citations
14.
Eijnde, Stefan M. van den, Maurice J.B. van den Hoff, Chris Reutelingsperger, et al.. (2001). Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. Journal of Cell Science. 114(20). 3631–3642. 245 indexed citations
15.
Machiels, Barbie M., Mieke E.R. Henfling, Will L.H. Gerards, et al.. (1997). Detailed analysis of cell cycle kinetics upon proteasome inhibition. Cytometry. 28(3). 243–252. 44 indexed citations
16.
Schutte, Bert, et al.. (1997). The Effect of the Cyclin-Dependent Kinase Inhibitor Olomoucine on Cell Cycle Kinetics. Experimental Cell Research. 236(1). 4–15. 93 indexed citations
17.
Machiels, Barbie M., Mieke E.R. Henfling, Will L.H. Gerards, et al.. (1997). Detailed analysis of cell cycle kinetics upon proteasome inhibition. Cytometry. 28(3). 243–252. 3 indexed citations
18.
Machiels, Barbie M., Mieke E.R. Henfling, J. L. V. Broers, Klavs B. Hendil, & F. C. S. Ramaekers. (1995). Changes in immunocytochemical detectability of proteasome epitopes depending on cell growth and fixation conditions of lung cancer cell lines.. PubMed. 66(3). 282–92. 15 indexed citations
19.
Graus, Y., Mieke E.R. Henfling, Jan J.G.M. Verschuuren, et al.. (1991). Age related resistance to experimental autoimmune myasthenia gravis in rats. Journal of Autoimmunity. 4(6). xxviii–xxviii. 23 indexed citations
20.
Nagelkerken, Lex, Mieke E.R. Henfling, & Peter van Breda Vriesman. (1985). Accessory cell function of thoracic duct nonlymphoid cells, dendritic cells, and splenic adherent cells in the Brown-Norway rat. Cellular Immunology. 93(2). 520–531. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ge Zhou Breakdown of academic impact, for papers by Christian Melle Breakdown of academic impact, for papers by Victor Stastny Breakdown of academic impact, for papers by Jay Shankar Breakdown of academic impact, for papers by Ayman Oweida Breakdown of academic impact, for papers by Alasdair C. Stamps Breakdown of academic impact, for papers by Mark T. Boyd Breakdown of academic impact, for papers by Maria Zajac‐Kaye Breakdown of academic impact, for papers by Shu-ichi Matsuzawa Breakdown of academic impact, for papers by Jerry Y. Hsu
Rankless by CCL
2026